Shire (LON: SHP)‘s stock had its “buy” rating restated by equities researchers at Jefferies Group in a report issued on Wednesday. They currently have a $37.17 (2400 GBX) target price on the stock.

Shares of Shire opened at 2079.00 on Wednesday. Shire has a 52 week low of GBX 1682.00 and a 52 week high of GBX 2270.00. The stock’s 50-day moving average is currently GBX 1877.. The company’s market cap is £11.472 billion.

A number of other analysts have also recently weighed in on SHP. Analysts at Deutsche Bank raised their price target on shares of Shire from $35.31 to $36.09 in a research note to investors on Tuesday. They now have a “buy” rating on the stock. Separately, analysts at JPMorgan Chase reiterated an “overweight” rating on shares of Shire in a research note to investors on Tuesday. They now have a $36.32 price target on the stock. Finally, analysts at UBS AG raised their price target on shares of Shire from $34.71 to $37.19 in a research note to investors on Friday, February 15th. They now have a “buy” rating on the stock.

Shire plc (Shire) is a specialty biopharmaceutical company that focuses on meeting the needs of the specialist physician.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.